What would cause ecchymosis in the anterior hip or groin region in a patient with pain during active hip flexion, potential iliopsoas muscle pathology, and taking anticoagulant medications such as warfarin (coumarin) or aspirin (acetylsalicylic acid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ecchymosis in the Anterior Hip/Groin Region: Anticoagulant-Related Iliopsoas Hemorrhage

In a patient with anterior hip/groin pain during active hip flexion and taking anticoagulants (warfarin or aspirin), the most likely cause of ecchymosis is spontaneous iliopsoas muscle hemorrhage, a potentially life-threatening complication that occurs in 12-14% of patients with bleeding disorders and is significantly increased by anticoagulant therapy. 1, 2, 3

Primary Mechanism: Anticoagulant-Induced Bleeding

Warfarin (Coumarin) Effects

  • Warfarin inhibits vitamin K-dependent clotting factors (II, VII, IX, X) and anticoagulant proteins C and S, resulting in sequential depression of coagulation cascade over 72-96 hours. 4
  • The drug has a narrow therapeutic index, and bleeding risk increases exponentially when INR exceeds 3.0-3.5. 5, 4
  • Major bleeding is defined as clinically overt bleeding with hemoglobin decrease ≥2 g/dL, which commonly occurs with iliopsoas hematomas. 6, 2

Aspirin (Acetylsalicylic Acid) Contribution

  • Aspirin inhibits platelet aggregation and causes gastric erosions, doubling bleeding risk when combined with other anticoagulants through both pharmacokinetic interactions and direct antiplatelet effects. 5, 4
  • Approximately one-third of patients presenting with hip fractures take aspirin regularly, creating significant bleeding risk when combined with other thromboprophylactic medications. 1

Clinical Presentation of Iliopsoas Hemorrhage

Cardinal Symptoms

  • Thigh, hip, and/or groin pain (present in nearly all cases) 2, 3
  • Hip flexion contracture—the patient holds the hip in flexed position to minimize pain 2, 3
  • Femoral nerve paresthesia in the distribution of the femoral nerve 2, 3, 7
  • Hemoglobin drop >2 g/dL 2
  • Pain aggravated by active hip flexion and hip extension 8, 9

Physical Examination Findings

  • Abdominal tenderness may be present 3
  • Quadriceps weakness (knee extensor weakness) due to femoral nerve compression 7, 9
  • Visible ecchymosis in the anterior hip/groin region from blood tracking superficially 2, 3

Diagnostic Approach

Imaging Confirmation

  • Ultrasonography confirms iliopsoas hematoma in all cases and should be the initial imaging modality. 3, 9
  • Computed tomography (CT) demonstrates fluid collection in the iliopsoas bursa/muscle and displacement of the femoral nerve. 8, 7, 9
  • MRI provides detailed soft tissue evaluation and can differentiate between bursitis and hematoma. 1, 9

Laboratory Assessment

  • Check INR immediately—target should be <2 for surgery and <1.5 for neuraxial procedures. 1
  • Complete blood count to assess hemoglobin drop (typically >2 g/dL). 2
  • Coagulation studies to guide reversal therapy if needed. 1

Risk Factors Specific to This Scenario

Anticoagulant-Related Factors

  • Warfarin therapy carries 3% annual risk of major bleeding with 0.6% case fatality rate. 1
  • Combination of warfarin plus aspirin approximately doubles bleeding risk compared to warfarin alone. 5, 6
  • High-intensity anticoagulation (INR 3.0-4.5) resulted in 53 major bleeding complications versus 6 on aspirin alone in the SPIRIT trial. 1

Patient-Specific Risk Factors

  • Age ≥65 years increases bleeding risk. 4
  • History of gastrointestinal bleeding or previous hemorrhage. 5, 4
  • Renal insufficiency or anemia. 4
  • Highly variable INRs. 4

Critical Pitfalls to Avoid

Delayed Recognition

  • Patients typically wait 3.8 ± 4 days before seeking medical attention, allowing hematoma expansion and nerve compression. 2
  • Do not dismiss groin pain in anticoagulated patients as simple musculoskeletal strain. 8, 7

Inadequate Anticoagulation Management

  • For warfarin reversal in major bleeding with elevated INR, administer 4-factor prothrombin complex concentrate (25-50 U/kg IV) plus vitamin K 5-10 mg by slow IV infusion. 6
  • Small amounts of vitamin K may be used to reverse warfarin effects to achieve INR <2 for surgery. 1
  • Aspirin should be withheld during inpatient stay unless indicated for unstable angina or recent/frequent transient ischemic attacks. 1

Misdiagnosis of Iliopsoas Pathology

  • Hip flexion pain with iliopsoas involvement can mimic FAI syndrome, labral tears, or bursitis—but ecchymosis strongly suggests hemorrhage rather than inflammatory pathology. 1
  • Electromyography can confirm femoral neuropathy and determine lesion severity and location. 9

Treatment Implications

Conservative vs. Surgical Management

  • Surgical drainage is indicated when symptoms are severe and disabling, particularly with femoral nerve palsy. 7
  • Mean duration of therapy is 18.7 ± 11.9 days with hospitalization of 12.3 ± 9.1 days. 2
  • Physical therapy should begin 6.0 ± 2.4 days after initiation of hemostatic therapy and last approximately 20 days. 3
  • Ultrasonographic findings typically resolve within 3 months from initial episodes. 3

Recurrence Risk

  • Low frequency of recurrent bleeding (2.8%) after appropriate treatment. 2
  • Patients with inhibitors to clotting factors remain hospitalized significantly longer (19.1 ± 5.8 days vs. 7.6 ± 7.8 days). 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Iliopsoas haemorrhage in patients with bleeding disorders--experience from one centre.

Haemophilia : the official journal of the World Federation of Hemophilia, 2003

Research

Iliopsoas haemorrhage in patients with haemophilia: results from one centre.

Haemophilia : the official journal of the World Federation of Hemophilia, 2005

Guideline

Ketoconazole and Warfarin Interaction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Astaxanthin Interactions with Anticoagulants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.